• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物制药产品中用于检测残留CHO宿主细胞DNA的定量实时PCR方法的开发与验证及样品预处理方法的优化

Development and Validation of Quantitative Real-Time PCR for the Detection of Residual CHO Host Cell DNA and Optimization of Sample Pretreatment Method in Biopharmaceutical Products.

作者信息

Zheng Weifeng, Jiang Lin, Lei Qing, Yang Jun, Gao Xuefeng, Wang Wanru, Zhang Yanli, Kong Tao, Chen Qiaoli, Li Gang

机构信息

The fourth research department, Lanzhou Institute of Biological Products Co., Ltd, No.888 Yanchang Road, Chengguan District, Lanzhou City, Gansu Province China.

出版信息

Biol Proced Online. 2019 Sep 1;21:17. doi: 10.1186/s12575-019-0105-1. eCollection 2019.

DOI:10.1186/s12575-019-0105-1
PMID:31496923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6717637/
Abstract

BACKGROUND

The presence of residual DNA carried by biological products in the body may lead to an increased oncogenicity, infectivity, and immunomodulatory risk. Therefore, current agencies including WHO, EU, and the FDA limited the accepted amounts of residual DNA (less than 10 ng or 100 pg/dose). Among the methods of detecting residual DNA, qPCR is considered to be the most practical for residual DNA quantitation due to its sensitivity, accuracy, precision, and time-saving.

RESULTS

In this study, the detection capacity of this method was determined by comparing the detected concentration of the commercial kit and the self-designed primer/probe set after the same treatment of the extraction method. Then, a universal sample pretreatment method based on a co-precipitant was optimized. The validation results demonstrated that the method has appropriate specificity, sensitivity, accuracy, and precision according to ICH guidelines. The limit of detection and quantitation reached 3 fg/ul and 0.3 pg/reaction respectively, which satisfies the requirement of limit of residual DNA detection in biologics. Spike recovery (82.3-105.7%) showed that the proposed qPCR assay was accurate and has good extraction efficiency. Moreover, the precision of the method based on intra- and inter-assay was 0.065-0.452% and 0.471-1.312%, respectively.

CONCLUSIONS

These results all indicated that the method for determination of residual DNA in biological products expressed from CHO cells is sensitive, accurate and robust.

摘要

背景

生物制品携带的残留DNA在体内的存在可能会导致致癌性、感染性和免疫调节风险增加。因此,包括世界卫生组织、欧盟和美国食品药品监督管理局在内的现行机构对残留DNA的可接受量进行了限制(每剂量小于10 ng或100 pg)。在检测残留DNA的方法中,定量聚合酶链反应(qPCR)因其灵敏度、准确性、精密度和省时性,被认为是残留DNA定量最实用的方法。

结果

在本研究中,通过比较商业试剂盒和自行设计的引物/探针组在相同提取方法处理后的检测浓度,确定了该方法的检测能力。然后,优化了一种基于共沉淀剂的通用样品预处理方法。验证结果表明,根据国际人用药品注册技术协调会(ICH)指南,该方法具有适当的特异性、灵敏度、准确性和精密度。检测限和定量限分别达到3 fg/ul和0.3 pg/反应,满足生物制品中残留DNA检测限的要求。加标回收率(82.3 - 105.7%)表明所提出的qPCR检测方法准确且具有良好的提取效率。此外,基于批内和批间的方法精密度分别为0.065 - 0.452%和0.471 - 1.312%。

结论

这些结果均表明,用于测定CHO细胞表达的生物制品中残留DNA的方法灵敏、准确且稳健。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6511/6717637/4a107b6dddc2/12575_2019_105_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6511/6717637/2efb3506d4bf/12575_2019_105_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6511/6717637/a45f2dcfcd86/12575_2019_105_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6511/6717637/efd5de758e9b/12575_2019_105_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6511/6717637/4a107b6dddc2/12575_2019_105_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6511/6717637/2efb3506d4bf/12575_2019_105_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6511/6717637/a45f2dcfcd86/12575_2019_105_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6511/6717637/efd5de758e9b/12575_2019_105_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6511/6717637/4a107b6dddc2/12575_2019_105_Fig4_HTML.jpg

相似文献

1
Development and Validation of Quantitative Real-Time PCR for the Detection of Residual CHO Host Cell DNA and Optimization of Sample Pretreatment Method in Biopharmaceutical Products.生物制药产品中用于检测残留CHO宿主细胞DNA的定量实时PCR方法的开发与验证及样品预处理方法的优化
Biol Proced Online. 2019 Sep 1;21:17. doi: 10.1186/s12575-019-0105-1. eCollection 2019.
2
Optimization and validation of DNA extraction and real-time PCR assay for the quantitative measurement of residual host cell DNA in biopharmaceutical products.用于生物制药产品中残留宿主细胞 DNA 定量测量的 DNA 提取和实时 PCR 分析方法的优化和验证。
J Pharm Biomed Anal. 2014 Jan;88:92-5. doi: 10.1016/j.jpba.2013.08.027. Epub 2013 Aug 30.
3
Quantitative detection of residual porcine host cell DNA by real-time PCR.通过实时聚合酶链式反应对残留猪宿主细胞DNA进行定量检测。
Biologicals. 2014 Mar;42(2):74-8. doi: 10.1016/j.biologicals.2013.10.005. Epub 2014 Jan 3.
4
A novel method for removing polyethyleneimine from biopharmaceutical samples: improving assay sensitivity of residual DNA qPCR.一种从生物制药样品中去除聚乙烯亚胺的新方法:提高残留 DNA qPCR 的检测灵敏度。
Biotechniques. 2020 Jun;68(6):353-358. doi: 10.2144/btn-2020-0011. Epub 2020 Mar 31.
5
Detection of residual E. coli host cell DNA by 23S ribosomal RNA gene-targeted quantitative polymerase chain reactions.采用 23S 核糖体 RNA 基因靶向定量聚合酶链反应检测残留的大肠杆菌宿主细胞 DNA。
J Pharm Biomed Anal. 2021 May 10;198:114000. doi: 10.1016/j.jpba.2021.114000. Epub 2021 Mar 2.
6
Quantitation of residual host cell DNA in protaminesulfate drug product by qPCR.采用 qPCR 法定量硫酸鱼精蛋白药物产品中的残留宿主细胞 DNA。
J Pharm Biomed Anal. 2018 Oct 25;160:238-243. doi: 10.1016/j.jpba.2018.07.052. Epub 2018 Jul 31.
7
A direct qPCR method for residual DNA quantification in monoclonal antibody drugs produced in CHO cells.一种用于定量检测CHO细胞生产的单克隆抗体药物中残留DNA的直接定量聚合酶链反应方法。
J Pharm Biomed Anal. 2015 Nov 10;115:603-6. doi: 10.1016/j.jpba.2015.03.005. Epub 2015 Mar 14.
8
Design and development of a simple method for the detection and quantification of residual host cell DNA in recombinant rotavirus vaccine.设计和开发一种简单的方法,用于检测和定量重组轮状病毒疫苗中的残留宿主细胞 DNA。
Mol Cell Probes. 2021 Feb;55:101674. doi: 10.1016/j.mcp.2020.101674. Epub 2020 Nov 27.
9
Comparison of SYBR Green and TaqMan real-time PCR methods for quantitative detection of residual CHO host-cell DNA in biopharmaceuticals.SYBR Green和TaqMan实时荧光定量PCR方法用于生物制药中残留CHO宿主细胞DNA定量检测的比较
Biologicals. 2015 Mar;43(2):130-5. doi: 10.1016/j.biologicals.2014.11.004. Epub 2014 Dec 4.
10
Development and qualification of a high sensitivity, high throughput Q-PCR assay for quantitation of residual host cell DNA in purification process intermediate and drug substance samples.用于定量纯化过程中间体和原料药样品中残留宿主细胞DNA的高灵敏度、高通量Q-PCR检测方法的开发与验证。
J Pharm Biomed Anal. 2014 Nov;100:145-149. doi: 10.1016/j.jpba.2014.07.037. Epub 2014 Aug 9.

引用本文的文献

1
Implementation of a high throughput automated platform for residual DNA quantitation.用于残留DNA定量的高通量自动化平台的实施。
PLoS One. 2025 Apr 24;20(4):e0322133. doi: 10.1371/journal.pone.0322133. eCollection 2025.
2
Evaluation of the Efficacy of the Vaccine Production Process in Removing Residual Host Cell DNA from the Vero Cell Rabies Vaccine.评价Vero细胞狂犬病疫苗生产工艺去除残留宿主细胞DNA的效果。
Vaccines (Basel). 2024 Dec 6;12(12):1379. doi: 10.3390/vaccines12121379.
3
Basic regulatory science behind drug substance and drug product specifications of monoclonal antibodies and other protein therapeutics.

本文引用的文献

1
Design and validation of a new method to detect and quantify residual host cell DNA in human recombinant erythropoietin (rEPO).一种检测和定量重组人促红细胞生成素(rEPO)中残留宿主细胞DNA的新方法的设计与验证
Prep Biochem Biotechnol. 2017 Oct 21;47(9):847-851. doi: 10.1080/10826068.2017.1320292. Epub 2017 Apr 20.
2
Universal real-time PCR assay for quantitation and size evaluation of residual cell DNA in human viral vaccines.用于定量和评估人用病毒疫苗中残留细胞DNA大小的通用实时聚合酶链反应检测法。
Biologicals. 2016 May;44(3):139-49. doi: 10.1016/j.biologicals.2016.03.002. Epub 2016 Mar 28.
3
A direct qPCR method for residual DNA quantification in monoclonal antibody drugs produced in CHO cells.
单克隆抗体及其他蛋白质疗法的原料药和制剂规格背后的基础监管科学。
J Pharm Anal. 2024 Jun;14(6):100916. doi: 10.1016/j.jpha.2023.12.006. Epub 2023 Dec 10.
4
PCR-based analytics of gene therapies using adeno-associated virus vectors: Considerations for cGMP method development.使用腺相关病毒载体的基因治疗的基于聚合酶链反应的分析:cGMP方法开发的注意事项。
Mol Ther Methods Clin Dev. 2023 Oct 27;31:101132. doi: 10.1016/j.omtm.2023.101132. eCollection 2023 Dec 14.
5
Fast Track Diagnostic Tools for Clinical Management of Sepsis: Paradigm Shift from Conventional to Advanced Methods.用于脓毒症临床管理的快速诊断工具:从传统方法到先进方法的范式转变
Diagnostics (Basel). 2023 Jan 11;13(2):277. doi: 10.3390/diagnostics13020277.
6
Development of a duplex qPCR assay with locked nucleic acid probes for A, B and E kappa-casein variants detection.建立一种采用锁核酸探针的双重实时荧光定量 PCR 方法,用于检测 A、B 和 E 型 κ-酪蛋白变异体。
Sci Rep. 2022 Sep 30;12(1):16387. doi: 10.1038/s41598-022-20586-w.
7
PCR-Based Analytical Methods for Quantification and Quality Control of Recombinant Adeno-Associated Viral Vector Preparations.基于聚合酶链反应的重组腺相关病毒载体制剂定量及质量控制分析方法
Pharmaceuticals (Basel). 2021 Dec 24;15(1):23. doi: 10.3390/ph15010023.
8
Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase.通过组合 AAV-intron-trap、CRISPR/Cas9 和诱导型 Cre 重组酶来生成可扩展的癌症模型。
Commun Biol. 2021 Oct 13;4(1):1184. doi: 10.1038/s42003-021-02690-1.
一种用于定量检测CHO细胞生产的单克隆抗体药物中残留DNA的直接定量聚合酶链反应方法。
J Pharm Biomed Anal. 2015 Nov 10;115:603-6. doi: 10.1016/j.jpba.2015.03.005. Epub 2015 Mar 14.
4
A mouse strain defective in both T cells and NK cells has enhanced sensitivity to tumor induction by plasmid DNA expressing both activated H-Ras and c-Myc.一种在T细胞和自然杀伤细胞(NK细胞)方面均存在缺陷的小鼠品系,对表达活化型H-Ras和c-Myc的质粒DNA诱导肿瘤具有更高的敏感性。
PLoS One. 2014 Oct 10;9(10):e108926. doi: 10.1371/journal.pone.0108926. eCollection 2014.
5
Direct real-time quantitative PCR for measurement of host-cell residual DNA in therapeutic proteins.用于测量治疗性蛋白质中宿主细胞残留DNA的直接实时定量PCR。
J Pharm Biomed Anal. 2014 Nov;100:123-130. doi: 10.1016/j.jpba.2014.07.032. Epub 2014 Aug 12.
6
Quantitation of the residual DNA from rice-derived recombinant human serum albumin.定量分析来源于水稻的重组人血清白蛋白的残留 DNA。
Anal Biochem. 2014 Apr 1;450:4-10. doi: 10.1016/j.ab.2013.12.033. Epub 2014 Jan 3.
7
PER.C6(®) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine.PER.C6(®)细胞作为无血清悬浮细胞平台用于生产高滴度脊髓灰质炎病毒:为世界供应灭活脊髓灰质炎病毒疫苗提供一种潜在的低成本选择。
Vaccine. 2013 Jan 21;31(5):850-6. doi: 10.1016/j.vaccine.2012.10.070. Epub 2012 Oct 30.
8
Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines.新型细胞作为人用疫苗基质的监管、生物安全和安全性挑战。
Vaccine. 2012 Apr 5;30(17):2715-27. doi: 10.1016/j.vaccine.2012.02.015. Epub 2012 Feb 17.
9
From brain passage to cell adaptation: the road of human rabies vaccine development.从脑部途径到细胞适应:人类狂犬病疫苗的发展之路。
Expert Rev Vaccines. 2011 Nov;10(11):1597-608. doi: 10.1586/erv.11.140.
10
Development of a quantitative PCR assay for residual mouse DNA and comparison of four sample purification methods for DNA isolation.定量 PCR 检测法用于检测残留的小鼠 DNA 并比较四种 DNA 提取样本纯化方法
J Pharm Biomed Anal. 2011 Apr 28;55(1):71-7. doi: 10.1016/j.jpba.2011.01.010. Epub 2011 Jan 19.